SAN DIEGO, June 6, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the "Class Period"), have until July 28, 2025 to seek...
Hence then, the article about urgn investor deadline urogen pharma ltd investors with substantial losses have opportunity to lead class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN INVESTOR DEADLINE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Ageless Jane Seymour Takes Halloween Inspiration From 2 Iconic Roles—Dr. Quinn and ‘James Bond’s’ Solitaire
- A duck farmer’s five-story house stood alone in a Chinese highway for over a year; it came down in 2012 for 260,000 yuan
- The 6 Best Low-Maintenance Pixie Cuts for Women Over 60 With Glasses, According to Celebrity Stylists